Sarepta Therapeutics, Inc. (SRPT) bonds
Close on Nov 17, 2026Market cap $1.56BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Sarepta Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Sarepta Therapeutics's 10-Q for the period ended Jun 30, 2026
Coupon by maturity
Each circle is a note, sized by the amount issued. The line is what the US Treasury pays today for the same time to maturity.
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| 2027 Notes | 1.25% | Sep 15, 2027 | – | $157.81M |
| Two Thousand And Twenty Seven Senior Convertible Notes Convertible at $142 a share | 1.25% | Sep 15, 2027 | $158.61M | – |
| 2030 Notes | 4.88% | Sep 1, 2030 | – | $689.82M |
| Two Thousand And Thirty Senior Convertible Notes Convertible at $60 a share | 4.88% | – | $893.39M | – |
| Two Thousand And Twenty Four Senior Convertible Notes Convertible at $73 a share | 1.50% | – | $570.00M | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Revolving Credit Facility | $600.00M |
See a number that looks wrong?